2627 — Ab&B Bio Tech JS Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: AB&B Bio Tech Co JS Says Li Runxiang Resigns As Executive Director And CFO
Brief: AB&B Bio Tech Announces Delay In Publication Of 2026 Interim Results And Report
Brief: Ab&B Bio Tech Enters Strategic Cooperation Agreement With Walvax Hong Kong
Ab&B Bio Tech hits record high on inclusion in Hang Seng Composite Index
Brief: AB&B Bio Tech Co Ltd JS Says H Shares Included In Hang Seng Composite Index Effective March 9
Ab&B gains as human rabies vaccine commences Phase III clinical trials
Brief: Ab&B Bio Tech Co Ltd JS Announces Approval For Quadrivalent Subunit Influenza Vaccine By China's NMPA
Brief: AB&B Says China CDE, U.S. FDA Approve IND Application Of Co's RSV Vaccine
Ab&B Bio-Tech soars on vaccine inclusion in China's national drug list
China's Ab&B Bio-Tech shares soar 170% driven by retail demand (updated)
China's Ab&B Bio-Tech shares soar 170% driven by retail investor frenzy
Brief: AB&B Bio Tech Co Ltd Js' Says Final Offer Price Under Global Offering HK$12.90 Per H Share